Patent · US Active

Product and method for treatment of conditions associated with receptor-desensitization

US7825224B2 · kind B2 · utility

9Cited by
2References
7Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJul 2, 2007
Grant dateNov 2, 2010
Priority date
Expiry dateSep 29, 2028

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/76
  • WIPO fieldMeasurement
  • WIPO sectorInstruments

Abstract

Particular members of the multisubunit immune recognition receptor (MIRR) family of receptors, specifically, the B cell antigen receptor (BCR), the pre-B cell receptor (pre-BCR), the pro-B cell receptor (pro-BCR), Ig Fc receptors (FcR), and NK receptors, can be physically uncoupled from their associated transducers. The invention describes regulatory compounds and methods for mimicking such dissociation/destabilization for the purposes of receptor desensitization and for treatment of conditions in which receptor desensitization or alternatively, enhanced or prolonged receptor sensitization, is desirable. Compounds and methods for enhancing or prolonging receptor sensitization are also disclosed, as are methods for identifying regulatory compounds suitable for use in the present methods.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.